Q4 2024 Holdings
Filed 2025-02-14 | 63 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bluebird BIO Inc(BLE0) | COM NEW | 09609G209 | $680.2K | 81,555 | 0.1% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.0M | 1,188,178 | 0.1% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.4M | 2,018,500 | 0.1% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $1.5M | 1,228,910 | 0.1% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $1.6M | 150,000 | 0.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.2M | 287,104 | 0.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.3M | 96,000 | 0.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $2.3M | 82,000 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.3M | 210,000 | 0.3% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $3.4M | 502,600 | 0.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $3.9M | 222,000 | 0.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $4.1M | 532,000 | 0.4% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $4.2M | 100,000 | 0.4% |
| Bruker Corp(BRKR) | COM | 116794108 | $4.5M | 76,300 | 0.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $6.0M | 8,400 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $6.8M | 352,124 | 0.7% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $7.9M | 7,477,200 | 0.8% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $8.0M | 7,966,400 | 0.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $8.1M | 97,000 | 0.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $8.3M | 222,900 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.5M | 62,000 | 0.8% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $8.6M | 2,694,600 | 0.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $9.0M | 129,600 | 0.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $9.1M | 354,000 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $10.2M | 1,265,200 | 1.0% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $10.9M | 514,200 | 1.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $11.3M | 1,390,100 | 1.1% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $12.0M | 192,400 | 1.2% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $12.2M | 215,000 | 1.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.2M | 1,053,300 | 1.3% |
| Arvinas Inc(ARVN)Call | COM | 04335A105 | $13.4M | 700,000 | 1.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $14.3M | 80,700 | 1.4% |
| Illumina Inc(ILMN) | COM | 452327109 | $14.7M | 109,700 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $14.8M | 352,000 | 1.5% |
| Danaher Corporation(DHR) | COM | 235851102 | $15.4M | 67,000 | 1.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $15.4M | 176,600 | 1.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $15.9M | 188,000 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $16.1M | 232,800 | 1.6% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $17.3M | 137,000 | 1.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $18.6M | 474,000 | 1.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $19.5M | 446,200 | 1.9% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $19.5M | 1,165,800 | 1.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $19.8M | 1,500,000 | 1.9% |
| Avantor Inc(AVTR) | COM | 05352A100 | $20.0M | 947,000 | 2.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $20.1M | 500,000 | 2.0% |
| Humana Inc(HUM) | COM | 444859102 | $22.6M | 89,200 | 2.2% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $23.2M | 44,600 | 2.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $24.7M | 318,000 | 2.4% |
| Glaukos Corp(GKOS) | COM | 377322102 | $25.5M | 170,000 | 2.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $26.0M | 1,358,000 | 2.6% |